Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Erythropoietin for Total Hip Joint Arthroplasty
0
Zitationen
1
Autoren
2001
Jahr
Abstract
Letters18 September 2001Erythropoietin for Total Hip Joint ArthroplastyBrian G. Feagan, MDBrian G. Feagan, MDUniversity of Western Ontario; London Clinical Trials Research Group; London, Ontario N6A 5K8, CanadaSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-135-6-200109180-00020 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail IN RESPONSE:Our study of transfusion practice reflected the “real world” management by surgeons of patients with total hip joint arthroplasty. This approach is more relevant than the alternative, suggested by Dr. Kontor, of imposing arbitrary, non–evidence-based strict transfusion criteria. Most participants (64%) in the second Canadian Orthopedic Perioperative Erythropoietin Study (COPES II) who received transfusion had a hemoglobin concentration less than 80 g/L. Most clinicians accept that treatment or prevention of this degree of anemia in elderly patients undergoing total hip joint arthroplasty is desirable.While we acknowledge that little evidence exists to support the notion that transfusion improves ...References1. Carson JL, Duff A, Berlin JA, Lawrence VA, Poses RM, Huber EC, et al . Perioperative blood transfusion and postoperative mortality. JAMA. 1998;279:199-205. [PMID: 9438739] CrossrefMedlineGoogle Scholar2. Zuccalà G, Bernabei R, Carbonin P. Perioperative blood transfusion [Letter]. JAMA. 1998;279:1610-2. [PMID: 9613903] CrossrefMedlineGoogle Scholar3. Hébert PC, Wells G, Blajchman MA, Marshall J, Martin C, Pagliarello G, et al . A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med. 1999;340:409-17. [PMID: 9971864] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: University of Western Ontario; London Clinical Trials Research Group; London, Ontario N6A 5K8, Canada PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics 18 September 2001Volume 135, Issue 6Page: 471KeywordsAnemiaAttentionBlood transfusionDeath ratesErythropoietinHemoglobinHip fracturesMortalitySurgeonsTotal hip arthroplasty ePublished: 18 September 2001 Issue Published: 18 September 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
Ähnliche Arbeiten
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 5.201 Zit.
Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial
2010 · 3.231 Zit.
Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma
2015 · 2.433 Zit.
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
2020 · 2.420 Zit.
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
1999 · 2.045 Zit.